Signup Crypto ETF Stocks News

Tapestry (NYSE:TPR) Insider Denise Kulikowsky Sells 5,810 Shares of Stock

Tapestry insider Denise Kulikowsky sold 5,810 shares of the company's stock for approximately $670,358, reducing her direct ownership by 21.56% to 21,136 shares. The company recently reported strong quarterly earnings of $1.32 EPS, beating analyst expectations, and increased its quarterly dividend. Despite a "Moderate Buy" consensus rating from analysts and a $175.12 price target, Tapestry's shares were trading below their 50-day and 200-day moving averages.

Source: MarketBeat
September 10, 2026 | 23:10:55
Category: General

Metagenomi CFO Pamela Wapnick sells $2,213 in tax-related stock By Investing.com

Metagenomi CFO Pamela Wapnick sold 1,911 shares of common stock worth $2,213 on September 8, 2026. This transaction was an automatic sale to cover tax withholding obligations from vesting restricted stock units and not a discretionary trade. The stock is currently trading at $1.17, just above its 52-week low, with analysts maintaining price targets between $5 and $9, suggesting it is undervalued.

Source: Investing.com UK
September 10, 2026 | 19:37:33
Category: General

Goose Creek Spreads Something Sweet with the New Smucker's Candle Collection

Goose Creek has launched a new candle collection inspired by iconic Smucker's jam flavors, available exclusively on GooseCreekCandle.com. The collection features four scents—Strawberry, Apple, Peach, and Cherry Jam—designed to evoke comfort and nostalgia. This collaboration aims to bring the beloved fruit-forward aromas of Smucker's into home fragrances for a limited time.

Source: ACCESS Newswire
September 10, 2026 | 20:09:30
Category: General

Apple is walking a ‘tightrope’ when it comes to the prices of its new iPhones

Apple is facing a pricing dilemma for its new iPhones, including the iPhone 18 Pro line and its first foldable phone, the Duo. Analysts suggest the company may need to absorb some costs to maintain sales amidst rising inflation and constrained consumer spending. The challenge lies in balancing increased production costs with consumers' limited ability to pay higher prices for new devices.

Source: MarketWatch
September 10, 2026 | 20:19:16
Category: General

Fortive Announces Appointment of Susan Main to Its Board of Directors

Fortive Corporation (NYSE: FTV) announced the appointment of Susan L. Main to its Board of Directors, effective September 9, 2026, expanding the board to nine members. Ms. Main, who previously served as SVP and CFO of Teledyne Technologies, will also join Fortive's Audit Committee. Her extensive financial and operational expertise, along with her experience as a public company director, are expected to be valuable assets to Fortive's governance and strategic initiatives.

Source: Yahoo Finance
September 10, 2026 | 20:30:13
Category: General

Kadant board approves $0.36 quarterly dividend By Investing.com

Kadant Inc. (NYSE: KAI) has announced that its board of directors has approved a quarterly cash dividend of $0.36 per share. This dividend is scheduled to be paid on November 12, 2026, to shareholders recorded as of October 15, 2026. Kadant, a global supplier of technologies and engineered systems for process industries, stated that future dividend declarations are subject to board approval and potential adjustments based on business needs or market conditions.

Source: Investing.com India
September 10, 2026 | 20:35:04
Category: General

MAA to Participate in the BofA Securities 2026 Global Real Estate Conference

Mid-America Apartment Communities, Inc. (MAA) announced its participation in the BofA Securities 2026 Global Real Estate Conference. A round table presentation is scheduled for Wednesday, September 16, 2026, at approximately 3:00 p.m. Eastern Time. A live webcast will be available on MAA's website.

Source: Yahoo! Finance Canada
September 10, 2026 | 20:38:30
Category: General

Lyell completes LYL273 manufacturing transfer, eyes 2027 FDA meeting By Investing.com

Lyell Immunopharma has completed the technology transfer for its LYL273 cancer treatment to its Bothell, Washington manufacturing facility, which implements an improved manufacturing process and increased capacity. LYL273 is a CAR T-cell product candidate for relapsed/refractory metastatic colorectal cancer, currently in a Phase 1/2 clinical trial. The company expects to release additional clinical data and hold an End-of-Phase 1 meeting with the FDA in 2027.

Source: Investing.com Canada
September 10, 2026 | 20:41:30
Category: General

Kadant stock slips on CEO succession plan announcement By Investing.com

Kadant Inc. (NYSE:KAI) shares dropped 1% in after-hours trading following the announcement of its CEO succession plan. Michael Colwell will become president and COO on October 1, 2026, and then president, CEO, and director on January 2, 2027, succeeding current CEO Jeffrey Powell, who will transition to executive chairman. The plan aims to ensure leadership continuity, with Powell remaining involved in strategic activities.

Source: Investing.com Australia
September 10, 2026 | 20:49:04
Category: General

Kadant Announces CEO Succession Plan

Kadant Inc. has announced a CEO succession plan where Michael C. Colwell will become president and COO on October 1, 2026, and then president, CEO, and a director on January 2, 2027. Current CEO Jeffrey L. Powell will transition to executive chairman on January 2, 2027, and Jonathan W. Painter will retire as chairman. The plan ensures leadership continuity, leveraging Colwell's experience and Powell's continued strategic involvement.

Source: The Manila Times
September 10, 2026 | 20:49:04
Category: General

© Natavest 2025 - 2026